---
figid: PMC3735785__nihms-481361-f0003
figlink: /pmc/articles/PMC3735785/figure/F3/
number: F3
caption: MLCK signaling in endothelial hyperpermeability. MLCK activity is increased
  by multiple signaling pathways in response to inflammatory mediators, downstream
  of G-protein coupled receptor (GPCR) activation. Activation of phospholipase C (PLC)
  leads to hydrolysis of phosphatidylinositol bisphosphate (PIP2) into diacylglycerol
  (DAG) and inositol triphosphate (IP3). IP3 triggers intracellular Ca++ release from
  intracellular stores (endoplasmic reticulum (ER)) via activation of the IP3 receptor.
  Stores Ca++ release activates MLCK directly through Ca++ binding to calmodulin (CaM).
  DAG and Ca++ together activate PKC-α and other classical PKC isoforms. PKC-α activates
  endothelial nitric oxide synthase (eNOS) (inhibited by PKC-ζ mediated phosphorylation
  at T497) by phosphorylation at S1179, to increase nitric oxide (NO) production.
  NO activates many signaling processes, including NO combines with reactive oxygen
  species (ROS) to form peroxynitrite (ONOO−); NO causes S-nitrosylation of numerous
  proteins; NO impairs function of complex IV of the mitochondrial oxidative phosphorylation
  system causing release of sequestered Ca++; and NO activates guanylate cyclase (GC)
  to increase conversion of guanosine triphosphate (GTP) into cyclic guanosine monophosphate
  (cGMP). cGMP can increase or decrease endothelial permeability through various mechanisms
  depending upon the cell type examined. cGMP activates MLCK through activation of
  PKG, which may be mediated through activation of the Raf-MEK-ERK pathway. cGMP may
  also modulate phosphodiesterase activity to increase or decrease abundance of cAMP
  and correspondingly affect PKA activity.
pmcid: PMC3735785
papertitle: Myosin Light Chain Kinase Signaling in Endothelial Barrier Dysfunction.
reftext: Robert R. Rigor, et al. Med Res Rev. ;33(5):911-933.
pmc_ranked_result_index: '107198'
pathway_score: 0.925032
filename: nihms-481361-f0003.jpg
figtitle: MLCK signaling in endothelial hyperpermeability
year: ''
organisms: Homo sapiens
ndex: 2c2061cf-df0d-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3735785__nihms-481361-f0003.html
  '@type': Dataset
  description: MLCK signaling in endothelial hyperpermeability. MLCK activity is increased
    by multiple signaling pathways in response to inflammatory mediators, downstream
    of G-protein coupled receptor (GPCR) activation. Activation of phospholipase C
    (PLC) leads to hydrolysis of phosphatidylinositol bisphosphate (PIP2) into diacylglycerol
    (DAG) and inositol triphosphate (IP3). IP3 triggers intracellular Ca++ release
    from intracellular stores (endoplasmic reticulum (ER)) via activation of the IP3
    receptor. Stores Ca++ release activates MLCK directly through Ca++ binding to
    calmodulin (CaM). DAG and Ca++ together activate PKC-α and other classical PKC
    isoforms. PKC-α activates endothelial nitric oxide synthase (eNOS) (inhibited
    by PKC-ζ mediated phosphorylation at T497) by phosphorylation at S1179, to increase
    nitric oxide (NO) production. NO activates many signaling processes, including
    NO combines with reactive oxygen species (ROS) to form peroxynitrite (ONOO−);
    NO causes S-nitrosylation of numerous proteins; NO impairs function of complex
    IV of the mitochondrial oxidative phosphorylation system causing release of sequestered
    Ca++; and NO activates guanylate cyclase (GC) to increase conversion of guanosine
    triphosphate (GTP) into cyclic guanosine monophosphate (cGMP). cGMP can increase
    or decrease endothelial permeability through various mechanisms depending upon
    the cell type examined. cGMP activates MLCK through activation of PKG, which may
    be mediated through activation of the Raf-MEK-ERK pathway. cGMP may also modulate
    phosphodiesterase activity to increase or decrease abundance of cAMP and correspondingly
    affect PKA activity.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PDE7A
  - PRKACG
  - PLCD3
  - PLCE1
  - PDE6C
  - PRKAR2B
  - PRKAR2A
  - PRKACB
  - MAPK1
  - PRKAR1B
  - PLCB1
  - PRKCA
  - PDE6A
  - VEGFC
  - PDE8B
  - PDE8A
  - MAPK3
  - PRKACA
  - PLCD1
  - PLCG1
  - PDE4C
  - PDE4D
  - VEGFB
  - GC
  - PDE11A
  - WDTC1
  - PDE1B
  - PDE6B
  - KRIT1
  - PRKAR1A
  - PLCB4
  - VEGFD
  - PGF
  - ARHGEF12
  - VEGFA
  - PLCB2
  - MFAP1
  - PDE2A
  - PDE10A
  - PDE4B
  - PDE4A
  - RAF1
  - NOS3
  - PDE3A
  - PDE9A
  - PDE1C
  - PLCZ1
  - PLCD4
  - PLCB3
  - BRAF
  - PDE7B
  - ARAF
  - PDE1A
  - PLCG2
  - PDE3B
  - histamine
genes:
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE7A
  entrez: '5150'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD3
  entrez: '113026'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCE1
  entrez: '51196'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE6C
  entrez: '5146'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB1
  entrez: '23236'
- word: PKCa
  symbol: PKCA
  source: hgnc_prev_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE6A
  entrez: '5145'
- word: (VEGF,
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE8B
  entrez: '8622'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE8A
  entrez: '5151'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD1
  entrez: '5333'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCG1
  entrez: '5335'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE4C
  entrez: '5143'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE4D
  entrez: '5144'
- word: (VEGF,
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: GC
  symbol: GC
  source: hgnc_symbol
  hgnc_symbol: GC
  entrez: '2638'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE11A
  entrez: '50940'
- word: ADP
  symbol: ADP
  source: hgnc_alias_symbol
  hgnc_symbol: WDTC1
  entrez: '23038'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE1B
  entrez: '5153'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE6B
  entrez: '5158'
- word: CaM
  symbol: CAM
  source: hgnc_alias_symbol
  hgnc_symbol: KRIT1
  entrez: '889'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB4
  entrez: '5332'
- word: (VEGF,
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: (VEGF,
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: L-arg
  symbol: LARG
  source: hgnc_alias_symbol
  hgnc_symbol: ARHGEF12
  entrez: '23365'
- word: (VEGF,
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB2
  entrez: '5330'
- word: AMP
  symbol: AMP
  source: hgnc_alias_symbol
  hgnc_symbol: MFAP1
  entrez: '4236'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE2A
  entrez: '5138'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE10A
  entrez: '10846'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE4B
  entrez: '5142'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE4A
  entrez: '5141'
- word: RAF1
  symbol: RAF1
  source: hgnc_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: ENOS
  symbol: eNOS
  source: hgnc_alias_symbol
  hgnc_symbol: NOS3
  entrez: '4846'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE3A
  entrez: '5139'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE9A
  entrez: '5152'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE1C
  entrez: '5137'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCZ1
  entrez: '89869'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD4
  entrez: '84812'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB3
  entrez: '5331'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE7B
  entrez: '27115'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE1A
  entrez: '5136'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCG2
  entrez: '5336'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE3B
  entrez: '5140'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
chemicals:
- word: histamine
  source: MESH
  identifier: D006632
diseases: []
figid_alias: PMC3735785__F3
redirect_from: /figures/PMC3735785__F3
figtype: Figure
---
